Sunday, 21 June 2020

Combination Biomarker Benefits Patients With Advanced Bladder Cancer

In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumor tissues was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors.


from Medindia Health News https://ift.tt/37PWBws

No comments:

Post a Comment